Business technology leaders said it’s nearly impossible to measure return on investment for AI at this point, and organizations should instead prioritize innovation and the most promising projects, The Wall Street Journal reported.
Many AI projects are still in the proof-of-concept phase, so businesses should be narrowing down what the best ideas are rather than focusing on ROI or productivity gains, leaders said at the WSJ Leadership Institute’s Technology Council Summit on Sept. 16.
“It’s really important to balance the focus on a few key areas with experimentation and learning, and even taking some risks at times,” Bryan Goodman, director of AI at Ford, said at the event. “At the end of the day, that’s where value is created.”
Only after an AI project is scaled across an organization can ROI be truly measured, some tech leaders said, while some businesses are taking a top-down approach to AI instead of letting employees freely experiment with the technology, according to the Sept. 16 story.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
